The 33rd China Pharmaceutical Industry Annual Conference (2016) was held recently in Chongqing, Sichuan, and the list of “Top 100 National Pharmaceutical Companies (2015)” was announced during the conference. ASK Pharm has once again successfully secured a position on this list. ASK Pharm’s ranking at the 70th this year was much improved in comparison to the 81st position last year. This is the seventh consecutive year that ASK Pharm has been awarded this prestigious national honor. In addition, ASK Pharm has also secured the 9th position on the list of “Top 20 National Pharmaceutical Innovators in Product Research and Development (2016)”, another significant indicator of corporate capacity in production and innovation.
ASK Pharm launched 3 brand-new proprietary products earlier this year, and has successfully maintained the national leadership in brand-name preparations of proton-pump inhibitors (PPIs) over the years. The corporate has also consistently ranked on top in new drug application and registration, and establishment of key R&D laboratories in order to expand product research and development. The recognition of ASK Pharm by the national pharmaceutical industry has very well illustrated the Corporate Vision of “Based on Research, Oriented for Health”; we endeavor to make continuous efforts to secure these national honors and to improve the health and wellbeing of the public.